130 related articles for article (PubMed ID: 17488351)
1. The critical role of myosin IIA in platelet internal contraction.
Johnson GJ; Leis LA; Krumwiede MD; White JG
J Thromb Haemost; 2007 Jul; 5(7):1516-29. PubMed ID: 17488351
[TBL] [Abstract][Full Text] [Related]
2. Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets.
Klages B; Brandt U; Simon MI; Schultz G; Offermanns S
J Cell Biol; 1999 Feb; 144(4):745-54. PubMed ID: 10037795
[TBL] [Abstract][Full Text] [Related]
3. Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human platelets.
Minuz P; Fumagalli L; Gaino S; Tommasoli RM; Degan M; Cavallini C; Lecchi A; Cattaneo M; Lechi Santonastaso C; Berton G
Biochem J; 2006 Nov; 400(1):127-34. PubMed ID: 16859489
[TBL] [Abstract][Full Text] [Related]
4. MyosinIIa contractility is required for maintenance of platelet structure during spreading on collagen and contributes to thrombus stability.
Calaminus SD; Auger JM; McCarty OJ; Wakelam MJ; Machesky LM; Watson SP
J Thromb Haemost; 2007 Oct; 5(10):2136-45. PubMed ID: 17645784
[TBL] [Abstract][Full Text] [Related]
5. Platelet shape change is mediated by both calcium-dependent and -independent signaling pathways. Role of p160 Rho-associated coiled-coil-containing protein kinase in platelet shape change.
Paul BZ; Daniel JL; Kunapuli SP
J Biol Chem; 1999 Oct; 274(40):28293-300. PubMed ID: 10497186
[TBL] [Abstract][Full Text] [Related]
6. Rho-kinase-mediated regulation of receptor-agonist-stimulated smooth muscle contraction.
Tsai MH; Jiang MJ
Pflugers Arch; 2006 Nov; 453(2):223-32. PubMed ID: 16953424
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
8. Mildly oxidised low density lipoprotein induces platelet shape change via Rho-kinase-dependent phosphorylation of myosin light chain and moesin.
Retzer M; Siess W; Essler M
FEBS Lett; 2000 Jan; 466(1):70-4. PubMed ID: 10648815
[TBL] [Abstract][Full Text] [Related]
9. Dichotomous regulation of myosin phosphorylation and shape change by Rho-kinase and calcium in intact human platelets.
Bauer M; Retzer M; Wilde JI; Maschberger P; Essler M; Aepfelbacher M; Watson SP; Siess W
Blood; 1999 Sep; 94(5):1665-72. PubMed ID: 10477691
[TBL] [Abstract][Full Text] [Related]
10. 5,6-EET-induced contraction of intralobar pulmonary arteries depends on the activation of Rho-kinase.
Losapio JL; Sprague RS; Lonigro AJ; Stephenson AH
J Appl Physiol (1985); 2005 Oct; 99(4):1391-6. PubMed ID: 15961610
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid stimulation of platelets rapidly induces Ca2+-dependent dephosphorylation of cofilin that is independent of dense granule secretion and aggregation.
Pandey D; Goyal P; Siess W
Blood Cells Mol Dis; 2007; 38(3):269-79. PubMed ID: 17321765
[TBL] [Abstract][Full Text] [Related]
12. Convulxin induces platelet shape change through myosin light chain kinase and Rho kinase.
Riondino S; Gazzaniga PP; Pulcinelli FM
Eur J Biochem; 2002 Dec; 269(23):5878-84. PubMed ID: 12444976
[TBL] [Abstract][Full Text] [Related]
13. Rho-kinase contributes to diphosphorylation of myosin II regulatory light chain in nonmuscle cells.
Ueda K; Murata-Hori M; Tatsuka M; Hosoya H
Oncogene; 2002 Aug; 21(38):5852-60. PubMed ID: 12185584
[TBL] [Abstract][Full Text] [Related]
14. Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways.
Wraith KS; Magwenzi S; Aburima A; Wen Y; Leake D; Naseem KM
Blood; 2013 Jul; 122(4):580-9. PubMed ID: 23699602
[TBL] [Abstract][Full Text] [Related]
15. The effects of the Rho-kinase inhibitor Y-27632 on arachidonic acid-, GTPgammaS-, and phorbol ester-induced Ca2+-sensitization of smooth muscle.
Fu X; Gong MC; Jia T; Somlyo AV; Somlyo AP
FEBS Lett; 1998 Nov; 440(1-2):183-7. PubMed ID: 9862451
[TBL] [Abstract][Full Text] [Related]
16. cGMP signaling inhibits platelet shape change through regulation of the RhoA-Rho Kinase-MLC phosphatase signaling pathway.
Aburima A; Walladbegi K; Wake JD; Naseem KM
J Thromb Haemost; 2017 Aug; 15(8):1668-1678. PubMed ID: 28509344
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric distribution of myosin IIB in migrating endothelial cells is regulated by a rho-dependent kinase and contributes to tail retraction.
Kolega J
Mol Biol Cell; 2003 Dec; 14(12):4745-57. PubMed ID: 12960430
[TBL] [Abstract][Full Text] [Related]
18. Agonist-induced regulation of myosin phosphatase activity in human platelets through activation of Rho-kinase.
Suzuki Y; Yamamoto M; Wada H; Ito M; Nakano T; Sasaki Y; Narumiya S; Shiku H; Nishikawa M
Blood; 1999 May; 93(10):3408-17. PubMed ID: 10233893
[TBL] [Abstract][Full Text] [Related]
19. Rho-kinase inhibitor inhibits both myosin phosphorylation-dependent and -independent enhancement of myofilament Ca2+ sensitivity in the bovine middle cerebral artery.
Maeda Y; Hirano K; Nishimura J; Sasaki T; Kanaide H
Br J Pharmacol; 2003 Nov; 140(5):871-80. PubMed ID: 14530221
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid-induced platelet shape change proceeds via Rho/Rho kinase-mediated myosin light-chain and moesin phosphorylation.
Retzer M; Essler M
Cell Signal; 2000 Oct; 12(9-10):645-8. PubMed ID: 11080616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
